Background. Concerns have been raised about both over- and underutilization of colorectal cancer (CRC) screening in older patients and the need to align screening behavior with likelihood of net benefit. Objective. The purpose of this study was to test a novel use of a patient decision aid (PtDA) to promote appropriate CRC screening in older adults. Methods. A total of 424 patients ages 70 to 84 y who were not up to date with CRC screening participated in a double-blinded randomized controlled trial of a PtDA targeted to older adults making decisions about whether to undergo CRC screening from March 2012 to February 2015. Intervention. Patients were randomized to a targeted PtDA or an attention control. The PtDA was designed to facilitate individualized decision making—helping patients understand the potential risks, benefits, and uncertainties of CRC screening given advanced age, health state, preferences, and values. Outcomes. Two composite outcomes, appropriate CRC screening behavior 6 mo after the index visit and appropriate screening intent immediately after the visit, were defined as completed screening or intent for patients in good health, discussion about screening with their provider for patients in intermediate health, and no screening or intent for patients in poor health. Health state was determined by age and Charlson Comorbidity Index. Results. Four hundred twelve (97%) and 421 (99%) patients were analyzed for the primary and secondary outcomes, respectively. Appropriate screening behavior at 6 mo was higher in the intervention group (55% v. 45%, P = 0.023) as was appropriate screening intent following the provider visit (61% v. 47%, P = 0.003). Limitations. The study took place in a single geographic region. The appropriate CRC screening classification system used in this study has not been formally validated. Conclusions. A PtDA for older adults promoted appropriate CRC screening behavior and intent.
HoldenDJJonasDEPorterfieldDSReulandDHarrisR. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152:668–676.
2.
WalterLCCovinskyKE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285:2750–2756.
Garcia-AlbenizXHsuJBretthauerMHernanMA. Effectiveness of screening colonoscopy to prevent colorectal cancer among Medicare beneficiaries aged 70 to 79 years: a prospective observational study. Ann Intern Med. 2017;166(1):18–26.
5.
WarrenJLKlabundeCNMariottoABet al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150:849–857, w152.
US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315:2564–75.
8.
KahiCJAzzouzFJuliarBEImperialeTF. Survival of elderly persons undergoing colonoscopy: implications for colorectal cancer screening and surveillance. Gastrointest Endosc. 2007;66:544–50.
9.
BellizziKMBreslauESBurnessAWaldronW. Prevalence of cancer screening in older, racially diverse adults: still screening after all these years. Arch Intern Med. 2011;171:2031–7.
10.
HeflinMTOddoneEZPieperCFBurchettBMCohenHJ. The effect of comorbid illness on receipt of cancer screening by older people. J Am Geriatr Soc. 2002;50:1651–8.
11.
SimaCSPanageasKSSchragD. Cancer screening among patients with advanced cancer. JAMA. 2010;304:1584–91.
12.
PowellAASainiSDBreitensteinMKet al. Rates and correlates of potentially inappropriate colorectal cancer screening in the veterans health administration. J Gen Intern Med. 2015;30:732–41.
13.
SainiSDVijanSSchoenfeldPPowellAAMoserSKerrEA. Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study. BMJ. 2014;348:g1247.
14.
BreslauESGorinSSEdwardsHMSchonbergMASaiontzNWalterLC. An individualized approach to cancer screening decisions in older adults: a multilevel framework. J Gen Intern Med. 2016;31:539–47.
15.
EckstromEFeenyDHWalterLCPerdueLAWhitlockEP. Individualizing cancer screening in older adults: a narrative review and framework for future research. J Gen Intern Med. 2013;28:292–8.
16.
SalzmanBBeldowskiKde la PazA. Cancer screening in older patients. Am Fam Physician. 2016;93:659–67.
17.
JimboMRanaGKHawleySet al. What is lacking in current decision aids on cancer screening?CA Cancer J Clin. 2013;63:193–214.
18.
DolanJGFrisinaS. Randomized controlled trial of a patient decision aid for colorectal cancer screening. Med Decis Making. 2002;22:125–39.
19.
SchonbergMAHamelMBDavisRBet al. Development and evaluation of a decision aid on mammography screening for women 75 years and older. JAMA Intern Med. 2014;174:417–24.
20.
StaceyDLegareFColNFet al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1:CD001431.
21.
LewisCLEssermanDDeLeonCPignoneMPPathmanDEGolinC. Physician decision making for colorectal cancer screening in the elderly. J Gen Intern Med. 2013;28:1202–7.
22.
LewisCLMooreCGGolinCEGriffithJTytell-BrennerAPignoneMP. Resident physicians’ life expectancy estimates and colon cancer screening recommendations in elderly patients. Med Decis Making. 2008;28:254–61.
23.
O’ConnorAMLlewellyn-ThomasHAFloodAB. Modifying unwarranted variations in health care: shared decision making using patient decision aids. Health Aff (Millwood). 2004;(Suppl Variation):Var63–72.
24.
KistlerCEGolinCMorrisCet al. Design of a randomized clinical trial of a colorectal cancer screening decision aid to promote appropriate screening in community-dwelling older adults. Clin Trials. 2017;14(6):648–58.
25.
WinawerSJZauberAGO’BrienMJet al. The National Polyp Study. Design, methods, and characteristics of patients with newly diagnosed polyps. The National Polyp Study Workgroup. Cancer. 1992;70:1236–45.
26.
AtkinWSMorsonBCCuzickJ. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658–62.
27.
WinawerSJZauberAGFletcherRHet al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006;130:1872–85.
RoyceTJHendrixLHStokesWAAllenIMChenRC. Cancer screening rates in individuals with different life expectancies. JAMA Intern Med. 2014;174(10):1558–65.
30.
KistlerCEKirbyKALeeDCasadeiMAWalterLC. Long-term outcomes following positive fecal occult blood test results in older adults: benefits and burdens. Arch Intern Med. 2011;171:1344–51.
31.
CallahanCMUnverzagtFWHuiSLPerkinsAJHendrieHC. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care. 2002;40:771–81.
32.
HardcastleJDChamberlainJORobinsonMHet al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–77.
33.
MandelJSBondJHChurchTRet al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71.
34.
KozukaSNogakiMOzekiTMasumoriS.
Premalignancy of the mucosal polyp in the large intestine: II. Estimation of the periods required for malignant transformation of mucosal polyps. Dis Colon Rectum. 1975;18:494–500.
35.
ChenXWhiteMCPeipinsLASeeffLC. Increase in screening for colorectal cancer in older Americans: results from a national survey. J Am Geriatr Soc. 2008;56:1511–6.
36.
WalterLCLindquistKNugentSet al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann Intern Med. 2009;150:465–73.
37.
FisherDAGalankoJDudleyTKShaheenNJ. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system. Clin Gastroenterol Hepatol. 2007;5:991–6.
38.
RoyceTJHendrixLHStokesWAAllenIMChenRC. Cancer screening rates in individuals with different life expectancies. JAMA Intern Med. 2014;174:1558–65.
39.
KistlerCEZimmermanSWardKTReedDGolinCLewisCL. Health of older adults in assisted living and implications for preventive care. Gerontologist. 2017;57(5):949–54.
40.
DeyoRACherkinDCCiolMA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.
41.
CharlsonMEPompeiPAlesKLMacKenzieCR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
42.
LewisCLGolinCEDeLeonCet al. A targeted decision aid for the elderly to decide whether to undergo colorectal cancer screening: development and results of an uncontrolled trial. BMC Med Inform Decis Mak. 2010;10:54.
43.
MathieuEBarrattADaveyHMMcGeechanKHowardKHoussamiN. Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Arch Intern Med. 2007;167:2039–46.
44.
QuigleyM. Nudging for health: on public policy and designing choice architecture. Med Law Rev. 2013;21:588–621.
45.
JohnsonEJShuSBDellaertBGCet al. Beyond nudges: tools of a choice architecture. Market Lett. 2012;23:487–504.
46.
DoakCCDoakLGRootJH. Teaching patients with low literacy skills. Am J Nurs. 1996;96:16M.
47.
LewisCLKistlerCEAmickHRet al. Older adults’ attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities. BMC Geriatr. 2006;6:1–8.
48.
ElwynGO’ConnorAStaceyDet al. Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ. 2006;333:417.
49.
O’ConnorAMTugwellPWellsGAet al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns. 1998;33:267–79.
50.
BarrettBBrownDMundtMBrownR. Sufficiently important difference: expanding the framework of clinical significance. Med Decis Making. 2005;25:250–61.
51.
KatzJNChangLCSanghaOFosselAHBatesDW. Can comorbidity be measured by questionnaire rather than medical record review?Med Care. 1996;34:73–84.
52.
TorkeAMSchwartzPHHoltzLRMontzKSachsGA. Older adults and forgoing cancer screening: “I think it would be strange.”JAMA Intern Med. 2013;173: 526–31.
53.
SheridanSLHarrisRPWoolfSH. Shared decision making about screening and chemoprevention: a suggested approach from the U.S. Preventive Services Task Force. Am J Prev Med. 2004;26:56–66.
54.
LewisCLAdamsJTai-SealeMet al. A randomized controlled effectiveness trial for PSA screening decision support interventions in two primary care settings. J Gen Intern Med. 2015;30(6):810–6.
55.
SajidSMohileSGSzmulewitzRPosadasEDaleW. Individualized decision-making for older men with prostate cancer: balancing cancer control with treatment consequences across the clinical spectrum. Semin Oncol. 2011;38:309–25.
56.
HerschJBarrattAJansenJet al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet. 2015;385:1642–52.
PurnellJQThompsonTKreuterMWMcBrideTD. Behavioral economics: “nudging” underserved populations to be screened for cancer. Prev Chronic Dis. 2015;12:E06.
59.
Blumenthal-BarbyJSCantorSBRussellHVNaikADVolkRJ. Decision aids: when ‘nudging’ patients to make a particular choice is more ethical than balanced, nondirective content. Health Aff (Millwood). 2013;32:303–10.
60.
KutnerJSBlatchfordPJTaylorDHJret al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015;175:691–700.
